Back
Robinhood Markets Vs. Akero Therapeutics Industry Stock Comparison
Buy
96
HOOD
Robinhood Markets
Last Price:
$64.82
Seasonality Move:
3.4%
Buy
64
AKRO
Akero Therapeutics
Last Price:
$48.97
Seasonality Move:
17.51%
Buy
96
Robinhood Markets (HOOD)
is a Buy
Is Robinhood Markets a Buy, Sell or Hold?
-
The current Robinhood Markets [HOOD] share price is $63.86. The Score for HOOD is 96, which is 92% above its historic median score of 50, and infers lower risk than normal.
-
HOOD is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
64
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $48.35. The Score for AKRO is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HOOD Stock Price Chart
What is Robinhood Markets's stock price today?
-
The Robinhood Markets share price today is $63.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HOOD is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $48.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
HOOD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.2 | Buy |
| Relative Strength Index (14 RSI): | 72.2 | Buy |
| Chaikin Money Flow: | -28061570 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.21 - 59.87) | Buy |
| Bollinger Bands (100): | (39.93 - 55.07) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.67 | Buy |
| Relative Strength Index (14 RSI): | 64.02 | Buy |
| Chaikin Money Flow: | 1418157 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.41 - 44.63) | Buy |
| Bollinger Bands (100): | (31.68 - 49.74) | Buy |
HOOD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 62.11 | Buy |
| 20-day SMA: | 54.63 | Buy |
| 50-day SMA: | 46.77 | Buy |
| 200-day SMA: | 37.4 | Buy |
| 8-day EMA: | 61.39 | Buy |
| 20-day EMA: | 55.85 | Buy |
| 50-day EMA: | 50.24 | Buy |
| 200-day EMA: | 39.52 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.54 | Buy |
| 20-day SMA: | 42.36 | Buy |
| 50-day SMA: | 41.34 | Buy |
| 200-day SMA: | 34.7 | Buy |
| 8-day EMA: | 43.02 | Buy |
| 20-day EMA: | 41.92 | Buy |
| 50-day EMA: | 41.49 | Buy |
| 200-day EMA: | 36.34 | Buy |
Robinhood Markets Earnings Growth & HOOD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.08 per share, an increase this year of $0.19 per share, and an increase next year of $0.25 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and a decrease next year of $0.69 per share.
Robinhood Markets Technical Analysis
| May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||